AbbVie Inc. (ABBV)
NYSE · Healthcare
AbbVie Inc. EPS 2011–2025
AbbVie Inc. annual/quarterly eps history and growth rate from 2011 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- AbbVie Inc. eps for the quarter ending March 31, 2026 was $0.39, a 45.83% decrease year-over-year.
- AbbVie Inc. annual eps for 2025 was $2.36, a 1.26% decrease from 2024.
- AbbVie Inc. annual eps for 2024 was $2.39, a 12.13% decrease from 2023.
- AbbVie Inc. annual eps for 2023 was $2.72, a 58.97% decrease from 2022.
- AbbVie Inc. annual eps for 2022 was $6.63.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
AbbVie Inc. EPS — FAQ
AbbVie Inc. (ABBV) eps over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is AbbVie Inc.'s eps?
AbbVie Inc. (ABBV) reported eps of $2.36 for fiscal 2025.
Where can I see ABBV's eps history?
The chart and table above show AbbVie Inc.'s eps by year and by quarter, including the growth rate.